Genetic screening in maternity care: Preventive aims and voluntary choices

Sociology of Health and Illness

Volumn 23, Issue 3, 2001, Pages 286-307

  Jallinoja, Piia ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Choice; Genetic screening; Information; Maternity care; Prenatal screening

Indexed keywords

EID: 0035324773     PISSN: 01419889     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-9566.00253     Document Type: Article

References (72)

1. Aula, P. (1997) Sikiötutkimukset [Prenatal diagnostics]. In Simell, O. and Simell, T. (eds) Neuvolakirja. Espoo: Orion.
2. Beauchamp, T. L. (1994) The 'Four Principles' approach. In Gillon R. (ed) Principles of Health Care Ethics. Chichester: John Wiley and Sons.
3. Bowker, G. C. and Star, S. L. (1999) Sorting Things Out. Classification and its Consequences. Cambridge: The MIT Press.
4. Chadwick, R. (1999) Genetics, choice and responsibility, Health, Risk and Society, 1, 293-300.
5. Collins, F.S., Patrinos, A., Jordan, E., Chakravarti, A., Gesteland, R. and Walters, L. et al. (1998) New goals for the U.S. Human Genome Project: 1998-2003, Science, 282, 682-9.
6. Council of Europe (1990) Recommendation on Prenatal Genetic Screening, Prenatal Genetic Diagnosis and Associated Genetic Counselling. R (90) 13.
7. Council of Europe (1992) Recommendation on Genetic Testing and Screening for Health Care Purposes. R (92) 3.
8. Cunningham-Burley, S. and Kerr, A. (1999) Defining the 'social': towards an understanding of scientific and medical discourses on the social aspects of the new human genetics, Sociology of Health and Illness, 21, 647-68.
9. Ettorre, E. (1999) Experts as 'storytellers' in reproductive genetics: exploring key issues, Sociology of Health and Illness, 21, 539-59.
10. Fujimura, J. (1988) The molecular biological bandwagon in cancer research: where social worlds meet, Social Problems, 35, 261-83.
11. Fujimura, J. (1992) Crafting science: standardized packages, boundary objects, and 'translation'. In Pickering, A. (ed) Science as Practice and Culture. Chicago: University of Chicago Press.
12. Fujimura, J. (1996) Crafting Science. A Sociohistory of the Quest for the Genetics of Cancer. Cambridge: Harvard University Press.
13. Geeniseulontatyöryhmä. (1998) Geeniseulontatyöryhmän muistio [Memo of the Working Group of Genetic Screening], Helsinki: Sosiaali-ja terveysministeriö.
14. Green, J. (1997) Risk and Misfortune. The Social Construction of Accidents. London: University College London Press.
15. Guidelines for the molecular genetics predictive test in Huntington's disease (1994) Neurology, 44, 1533-6.
16. Hellsten, E., Vesa, J., Speer, M., Mäkelä, T., Järvelä, I., Alitalo, K., Att, J. and Peltonen, L. (1993) Refined assignment of the infantile neuronal ceroid lipofuscinosis (INCL, CLN1) locus at 1p32: incorporation of linkage disequilibrium in multipoint analysis, Genomics, 16, 720-5.
17. Helsingin Sanomat, 8 February 1997. Parkkonen, M. (1997) Kahden geenivirheen seulonta lopetetiin Kuopion neuvoloissa. [Genetic screening for two gene defects was closed down in maternity care centres in Kuopio].
18. Hemminki, E., Malin, M. and Kojo-Austin, H. (1990) Prenatal care in Finland: from primary to tertiary health care, International Journal of Health Services, 20, 221-32.
19. Hemminki, E. and Gissler, M. (1993) Quality and targetting of antenatal care in Finland, Acta Obstetrics and Gynecologica Scandinavica, 72, 24-30.
20. Hermanson, T., Aro, S. and Bennett, C. (1994) Finland's health care system. Universal access to health care in a capitalistic democracy. Journal of American Medical Association, 271, 1957-62.
21. Hietala, M. (1998a) Prospects for Genetic Screening in Finland. Turku: University of Turku.
22. Hietala, M. (1998b). Personal communication with a gene researcher at Turku University Central Hospital.
23. Hietala, M., Grön, K., Syvänen, A,-C., Peltonen, L. and Aula, P. (1993) Prospects of carrier screening of aspartylglucosaminuria in Finland, European Journal of Human Genetics, 1, 296-300.
24. Hietala, M., Aula, P., Syvänen, A.-C., Isoniemi, A., Peltonen, L. and Palotie, A. (1996) DNA-based carrier screening in primary healthcare: screening for aspartylglucosaminuaria mutations in maternity health offices, Clinical Chemistry, 42, 1398-1404.
25. Hoedermaekers, R., ten Have, H. and Chadwick, R. (1997) Genetic screening: a comparative analysis of three recent reports, Journal of Medical Ethics, 23, 135-41.
26. Holtzman, N. and Shapiro, D. (1998) Genetic testing and public policy, British Medical Journal, 316, 852-6.
27. Jallinoja, P. and Aro, A. R. (1999) Lay people's knowledge of genes, heredity and gene tests, and attitudes towards gene tests and abortions. In Ettorre, E., Hemminki, E., Aro, A., Dragonas, T., Adams, E., van den Hueval, W., Tymstra, T., and Alderson, P. (eds) Final Report of the European Union Project on the Development of Prenatal Screening in Europe: the Past, the Present and the Future. University of Helsinki, Finland. (Contract number BMH4-CT96-0740).
28. Kerr, A., Cunningham-Burley, S. and Amos, A. (1998) Eugenics and the new genetics in Britain: examining contemporary professionals' accounts, Science, Technology and Human Values, 23, 175-98.
29. Koch, L. and Stemerding, D. (1994) The sociology of entrenchment: a cystic fibrosis test for everyone? Social Sciences and Medicine, 39, 1211-20.
30. Kuopion Sosiaali-ja terveyslautakunta. [Board of Social Affairs and Health] (1996) Raskaudenaikaisten AGU-ja Fragile-X -seulontojen jatkaminen [Countinuing of prenatal screening for AGU and Fragile X]. Dnro 240/2041/96, NRO 4, 110.
31. Kuopion yliopiston ja Kuopion yliopistollisen keskussairaalan eettinen toimikunta [Ethical committee of University of Kuopio and Kuopio University Hospital] (1994a). Lupa-anornus/suostumus/päätös tutkimustyön suorittamiseksi 208/94 [Licence application/approval/decision to conduct a research 208/94].
32. Kuopion yliopiston ja Kuopion yliopistollisen keskussairaalan eettinen toimikunta (1994b) Pöytäkirjaote 11/94. [Extract from the record 11/94].
33. Lancet (1999) Declaration of Helsinki - nothing to declare? Editorial. 353, 1285.
34. Latour, B. (1987) Science in Action. Milton Keynes: Open University Press.
35. Latour, B. (1988) The Pasteurization of France. Cambridge: Harvard University Press.
36. Latour, B. (1993) Ethnography of a 'high-tech' case. In Lemonnier P. (ed) Technological Choices. New York: Routledge.
37. Latour, B. (1994) On technical mediation - philosophy, sociology, genealogy. Common Knowledge, 3, 29-64.
38. Law, J. and Callon, M. (1992) The life and death of an aircraft: a network analysis of technical change. In Bijker, W. and Law, J. (eds) Shaping Technology/Building Society. Cambridge Massachusetts: The MIT Press.
39. Law, J. and Hassard, J. (eds) (1999) Actor Network and After. Oxford: Blackwell Publishers/The Sociological Review.
40. Law, J. and Singleton, V. (2000) This is Not an Object (draft). Published by the Centre for Science Studies and the Department of Sociology, Lancaster University at: http://www.lancaster.ac.uk/sociology/soc032jl.html
41. Lippman, A. (1999) Choice as a risk to women's health, Health, Risk and Society, 1, 281-91.
42. Lääkärin Etiikka. [Physician's Ethics] (1996) Helsinki: The Finnish Medical Association.
43. Mol, A. (1999) Ontological politics. A word and some questions. In Law J. and Hassard J. (eds) Actor Network and After. Oxford: Blackwell/The Sociological Review, Oxford.
44. Nelis, A. (1999) Managing genetic testing: the relative powerlessness of actors in stable practices, New Genetics and Society, 18, 125-44.
45. van Ommen, G. J. B, Bakker, E. and den Dunnen, J. T. (1999) The human genome project and the future of diagnostics, treatment, and prevention. The Lancet, 354, suppl., si5-si10.
46. Petersen, A. (1998) The new genetics and the politics of public health, Critical Public-Health, 8, 59-71.
47. Petersen, A. (1999) Counselling the genetically 'at risk': the poetics and politics of 'non-directiveness', Health, Risk and Society, 1, 253-65.
48. Petersen, A. and Lupton, D. (1996) The New Public Health. Health and Self in the Age of Risk. London: Sage.
49. Rose, N. (1999) Powers of Freedom. Reframing Political Thought. Cambridge: Cambridge University Press.
50. Ryynänen, M. (1982) Kehityshäiriöiden seulonta odottavan äidin seerumin alfafetoproteiinintutkimuksella Itä-Suomessa. [Screening for birth defects with maternal serum alpha-fetoprotein test in Eastern Finland]. Kuopio: Kuopion Korkeakoulu.
51. Ryynänen, M., Seppälä, M., Kuusela, P., Rapola J., Aula, P., Seppä, A., Jokela, V. and Castren, O. (1983) Antenatal screening for congenital nephrosis in Finland by maternal serum a-fetoprotein, British Journal of Obstetrics and Gynaecology, 90, 437-42.
52. Ryynänen, M. Pulkkinen, L., Kirkinen, P. and Saarikoski, S. (1994) Fragile-X syndrome in East Finland, American Journal of Medical Genetics, 51, 463-5.
53. Ryynänen, M., Kirkinen, P., Mannermaa, A. and Saarikoski, S. (1995) Carrier diagnosis of the Fragile X syndrome - A challenge in antenatal clinics, American Journal of Obstetrics and Gynaecology, 172, 1236-9.
54. Ryynänen, M. and Kirkinen, P. (1997) Odottavan äidin perinnöllisyysneuvonta. [Genetic counselling of pregnant women], Suomen Lääkärilehti, 52, 699-703.
55. Ryynänen, M., Heinonen, S., Makkonen, M., Mannermaa, A. and Kirkinen, P. (1998) Fragiili X -oireyhtymän mutaatioiden seulonta alkuraskauden aikana -tulokset ja äitien mielipiteet geenitestistä. [Screening for mutations of Fragile X during early pregnancy - results and opinions of mothers] Duodecim, 114, 2323-9.
56. Ryynänen, M., Heinonen, S., Makkonen, M., Kajanoja, E., Mannermaa, A. and Kirkinen, P. (1999) Feasibility and acceptance of screening for Fragile X mutation in low-risk pregnancies, European Journal of Human Genetics, 7, 212-16.
57. Saarikoski, S. and Ryynänen, M. (1995a) Geenitestit äitiysneuvolassa - vapaaehtoinen seulontatutkimus. Leaflet delivered to the mothers.
58. Saarikoski, S. and Ryynänen, M. (1995b) Fragiili-X oireyhtymä-perinnöllinen henkinen kehitysvammaisuus. Leaflet delivered to the mothers.
59. Santalahti, P., Hemminki, E., Aro, A.R., Helenius, H. and Ryynänen, M. (1999) Participation in prenatal screening tests and intentions concerning selective termination in Finnish maternity care, Fetal Diagnosis and Therapy, 14, 71-9.
60. Savon Sanomat, 30 September 1995. Juvonen-Papayiannakis, E. Geenivirheet selville neuvoloissa. [Gene defects are discovered at maternity care centres].
61. Savon Sanomat, 18 January 1997. Väisänen, M. (1997) Geeniseulonnat lopetettiin Kuopion äitiysneuvoloissa [Genetic screening was closed down in Kuopio maternity care centres].
62. Savon Sanomat, 12 April 1999. Vuorio, K. Hyvän ja pahan tiedon geenipuu [The gene tree of good and bad information].
63. Screening and Collaboration in Maternity Care. Guidelines 1995. (1996) Helsinki: National Research and Development Centre for Welfare and Health.
64. Shakespeare, T. (1998). Choice and rights: eugenics, genetics and disability equality, Disability and Society, 13, 665-81.
65. Singleton, V. and Michael, M. (1993) Actor-network and ambivalence: general practioners and the UK cervical screening programs. Social Studies of Science, 23, 227-64.
66. Star, S. Leigh and Griesemer, J. (1989) Institutional ecology, 'translations' and boundary objects: amateurs and professionals in Berkeley's Museum of Verbatile Zoology, 1907-39, Social Studies of Science, 19, 387-420.
67. Suomen Kuvalehti, 12 June 1998. Raatikainen, R. (1998) Geeneihin kirjoitettu [Written in the genes].
68. Syvänen, A.-C, Ikonen, E., Manninen, T., Bengtström, M., Söderlund, H., Aula, P. and Peltonen, L. (1992) Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland, Genomics, 12, 590-5.
69. Syvänen, A.-C., Järvelä I., Paunio, T. and Vesa, J. (1997) DNA diagnosis and identification of carriers of infantile and juvenile neuronal ceroid lipofuscinoses, Neuropediatrics, 28, 63-6.
70. Vesa, J., Hellsten, E., Verkruyse, L.A., Camp, L.A., Rapola, J., Santavuori, P., Hofmann, S.L. and Peltonen L. (1995) Mutations in the palmitoyl protein thioeserase gene causing infantile neuronal ceroid lipofuscinosis, Nature, 376, 584-7.
71. Wolpe, P. R. (1998) The triumph of autonomy in American bioethics: a sociological view. In DeVries, R. and Subedi, J. (eds) Bioethics and Society. Constructing the Ethical Enterprise. Upper Saddle River: Prentice Hall.
72. deVries, B., Halley, D., Oostra, B. and Niermeijer, M. (1998) The Fragile X syndrome, Journal of Medical Genetics, 35, 579-89.